Tarsons Products Limited
NSE: TARSONS BSE: TARSONS
Prev Close
359.75
Open Price
359.75
Volume
79,779
Today Low / High
341.35 / 368.9
52 WK Low / High
280 / 491.8
Range
327 - 362
Prev Close
359.1
Open Price
357.2
Volume
3,942
Today Low / High
340.6 / 364.95
52 WK Low / High
282 / 489
Range
326 - 360
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 344.5 (target range: 327 - 362), reflecting a change of -15.25 (-4.23905%). On the BSE, it is listed at 342.7 (target range: 326 - 360), showing a change of -16.4 (-4.56697%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Tarsons Products Limited Graph
Tarsons Products Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Tarsons Products Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 344.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 342.70 | 346.13 | 311.51 - 380.74 |
| 349.55 | 279.64 - 419.46 | ||
| 352.98 | 247.09 - 458.88 | ||
| Bearish Scenario | 342.70 | 339.27 | 305.35 - 373.20 |
| 335.85 | 268.68 - 403.02 | ||
| 332.42 | 232.69 - 432.14 |
Overview of Tarsons Products Limited
ISIN
INE144Z01023
Industry
Medical - Instruments & Supplies
Vol.Avg
63,385
Market Cap
18,292,319,064
Last Dividend
2
Official Website
IPO Date
2021-11-26
DCF Diff
1,005.86
DCF
-498
Financial Ratios Every Investor Needs
Stock Dividend of TARSONS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-20 | September 20, 24 | 2 | 2 | 2024-09-20 | 2024-10-27 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 392.41 Cr | 257.32 Cr | 135.09 Cr | 0.3443 | 0.00 Cr | 0.00 Cr | 48.23 Cr | 29.77 Cr | 5.60 | 126.69 Cr | 0.0759 |
| 2024-03-31 | 296.39 Cr | 94.29 Cr | 202.10 Cr | 0.6819 | 0.00 Cr | 45.06 Cr | 157.00 Cr | 42.64 Cr | 8.01 | 111.32 Cr | 0.1439 |
| 2023-03-31 | 283.25 Cr | 65.05 Cr | 218.19 Cr | 0.7703 | 0.00 Cr | 3.32 Cr | 101.25 Cr | 80.71 Cr | 15.17 | 141.70 Cr | 0.2850 |
| 2022-03-31 | 299.19 Cr | 80.06 Cr | 219.13 Cr | 0.7324 | 0.00 Cr | 2.67 Cr | 130.74 Cr | 100.66 Cr | 19.46 | 161.17 Cr | 0.3365 |
| 2021-03-31 | 227.91 Cr | 74.28 Cr | 153.63 Cr | 0.6741 | 0.00 Cr | 2.12 Cr | 92.18 Cr | 68.87 Cr | 13.43 | 108.82 Cr | 0.3022 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 25.65 Cr | 1,080.04 Cr | 449.83 Cr | 630.2110 Cr | 339.17 Cr | 313.51 Cr | 126.05 Cr | 704.66 Cr | 0.00 Cr | 0.00 Cr | 4.53 Cr | 175.7340 Cr |
| 2024-03-31 | 17.11 Cr | 972.18 Cr | 359.32 Cr | 612.8620 Cr | 269.02 Cr | 251.91 Cr | 133.20 Cr | 658.84 Cr | 0.82 Cr | 24.52 Cr | 0.07 Cr | 213.1550 Cr |
| 2023-03-31 | 59.06 Cr | 725.68 Cr | 156.38 Cr | 569.3030 Cr | 110.68 Cr | 51.63 Cr | 114.37 Cr | 343.30 Cr | 19.42 Cr | 7.27 Cr | 3.09 Cr | 62.9150 Cr |
| 2022-03-31 | 77.44 Cr | 544.23 Cr | 54.40 Cr | 489.8300 Cr | 21.67 Cr | -55.78 Cr | 82.37 Cr | 220.37 Cr | 5.00 Cr | 5.63 Cr | -2.52 Cr | 34.9140 Cr |
| 2021-03-31 | 2.33 Cr | 295.95 Cr | 51.61 Cr | 244.3380 Cr | 33.50 Cr | 31.17 Cr | 46.70 Cr | 141.93 Cr | -30.18 Cr | 3.16 Cr | 0.24 Cr | 41.7990 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 96.6200 Cr | -146.7310 Cr | 57.8120 Cr | -55.0870 Cr | 8.5420 Cr | 25.6520 Cr | -151.7070 Cr | 29.7700 Cr | 71.7380 Cr | -10.6340 Cr | 2.7820 Cr |
| 2024-03-31 | 102.7050 Cr | -284.9560 Cr | 135.6250 Cr | -81.6280 Cr | -41.9480 Cr | 17.1100 Cr | -184.3330 Cr | 60.7680 Cr | 145.9610 Cr | 0.0000 Cr | 7.5150 Cr |
| 2023-03-31 | 75.5990 Cr | -178.5480 Cr | 84.5610 Cr | -114.3690 Cr | -18.3840 Cr | 59.0580 Cr | -189.9680 Cr | 108.7200 Cr | 89.0890 Cr | 0.0000 Cr | -31.9990 Cr |
| 2022-03-31 | 83.4670 Cr | -137.9450 Cr | 129.5750 Cr | -48.5020 Cr | 75.1100 Cr | 77.4420 Cr | -131.9690 Cr | 134.9890 Cr | -11.8290 Cr | 0.0000 Cr | -35.7010 Cr |
| 2021-03-31 | 68.1550 Cr | -63.9110 Cr | -27.2230 Cr | 3.8330 Cr | -22.9790 Cr | 2.3320 Cr | -64.3220 Cr | 92.4340 Cr | -6.7680 Cr | 0.0000 Cr | 2.0310 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 112.69 Cr | 74.73 Cr | 37.97 Cr | 0.3369 | 17.00 Cr | 10.20 Cr | 1.92 | 40.80 Cr | 0.0905 |
| 2024-12-31 | 95.68 Cr | 31.25 Cr | 64.43 Cr | 0.6734 | 12.23 Cr | 5.26 Cr | 0.99 | 30.48 Cr | 0.0550 |
| 2024-09-30 | 99.25 Cr | 32.62 Cr | 66.63 Cr | 0.6713 | 11.28 Cr | 10.29 Cr | 1.93 | 33.73 Cr | 0.1037 |
| 2024-06-30 | 84.80 Cr | 54.79 Cr | 30.01 Cr | 0.3538 | 7.74 Cr | 4.02 Cr | 0.75 | 21.67 Cr | 0.0474 |
| 2024-03-31 | 105.72 Cr | 33.22 Cr | 72.51 Cr | 0.6858 | 21.30 Cr | 10.32 Cr | 1.94 | 33.63 Cr | 0.0976 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 25.65 Cr | 0.00 Cr | 25.65 Cr | 79.62 Cr | 126.05 Cr | 242.58 Cr | 704.66 Cr | 1,080.04 Cr | 449.83 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 36.36 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -613.91 Cr |
| 2024-09-30 | 19.96 Cr | 16.44 Cr | 36.40 Cr | 0.00 Cr | 139.36 Cr | 262.73 Cr | 630.07 Cr | 1,054.30 Cr | 440.40 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 22.61 Cr | 0.00 Cr | 0.00 Cr | 22.61 Cr | 0.00 Cr | 0.00 Cr | -612.86 Cr |
| 2024-03-31 | 17.11 Cr | 5.53 Cr | 22.64 Cr | 78.53 Cr | 128.73 Cr | 235.28 Cr | 533.69 Cr | 972.18 Cr | 359.32 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 5.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 10.29 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 4.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 10.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 9.93 Cr | 20.13 Cr | 0.00 Cr | 0.00 Cr | 20.13 Cr | 43.84 Cr | 23.71 Cr | 0.00 Cr | 20.13 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Instruments & Supplies
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Poly Medicure Limited | POLYMED | ₹1,846.30 | ₹187,078,193,800.00 | ₹468,416.00 |
| Dr. Agarwal's Health Care Limited | AGARWALEYE | ₹451.45 | ₹142,729,691,622.00 | ₹218,316.00 |
| Shaily Engineering Plastics Limited | SHAILY | ₹1,853.00 | ₹85,154,800,300.00 | ₹586,589.00 |
Key Executives
Gender: male
Year Born: 1988
Gender: male
Year Born: 1961
Gender: male
Year Born:
FAQs about Tarsons Products Limited
The CEO is Sanjive Sehgal.
The current price is ₹343.80.
The range is ₹280-494.95.
The market capitalization is ₹1,829.23 crores.
The dividend yield is 0.58%.
The P/E ratio is 61.35.
The company operates in the Healthcare sector.
Overview of Tarsons Products Limited (ISIN: INE144Z01023) is a leading Medical - Instruments & Supplies in India. With a market capitalization of ₹1,829.23 crores and an average daily volume of 63,385 shares, it operates in the Medical - Instruments & Supplies. The company last declared a dividend of ₹2.